SOURCE: ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

May 31, 2016 16:01 ET

ZELTIQ Aesthetics, Inc. to Present at Two Upcoming Conferences

PLEASANTON, CA --(Marketwired - May 31, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming conferences. The first presentation will be at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.

Event: Goldman Sachs 37th Annual Global Healthcare Conference
Date: Tuesday, June 7, 2016
Time: 3:20 pm PT/ 6:20 pm ET
Participants: Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer

The second presentation will be at the William Blair & Company's Growth Stock Conference in Chicago, IL.

Event: William Blair & Company's Growth Stock Conference
Date: Wednesday, June 15, 2016
Time: 8:40 pm CT/ 9:40 pm ET
Participant: Mark Foley, President and Chief Executive Officer

Audio webcast of the Company's presentations will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ® Aesthetics

ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.